Cedric O'Gorman's most recent trade in Relmada Therapeutics Inc was a trade of 10,000 Common Stock done at an average price of $3.2 . Disclosure was reported to the exchange on May 23, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relmada Therapeutics Inc | Cedric O'Gorman | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 3.18 per share. | 23 May 2023 | 10,000 | 10,121 (0%) | 0% | 3.2 | 31,800 | Common Stock |
| Relmada Therapeutics Inc | Cedric O'Gorman | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 400,000 | 400,000 | - | - | Stock Option (right to buy) |